Alpha-tocopherol succinate protects mice from gamma-radiation by induction of granulocyte-colony stimulating factor

References

• Birringer M, EyTina JH, Salvatore BA, Neuzil J. 2003. Vitamin E analogues as inducers of apoptosis: Structure-function relation. British Journal of Cancer 88:1948–1955.
   PubMed Web of Science ®Google Scholar
• Bociek RG, Armitage JO. 1996. Hematopoietic growth factors. CA: A Cancer Journal for Clinicians 46:165–184.
   PubMedGoogle Scholar
• Bronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, Testa NG, Dexter TM. 1987. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. British Journal of Cancer 56:809–813.
   PubMed Web of Science ®Google Scholar
• Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA, Liles WC, Li X, Graham-Evans B, Campbell TB, Calandra G, Bridger G, Dale DC, Srour EF. 2005. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. Journal of Experimental Medicine 201:1307–1318.
   PubMed Web of Science ®Google Scholar
• Burdelya LG, Krivokrysenko VI, Tallant TC, Strom E, Gleiberman AS, Gupta D, Kurnasov OV, Fort FL, Osterman AL, Didonato JA, Feinstein E, Gudkov AV. 2008. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 320:226–230.
   PubMed Web of Science ®Google Scholar
• Ciernik IF, Schanz U, Gmur J. 1999. Delaying treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for hematological malignancies: A prospective randomized trial. Bone Marrow Transplantation 24:147–151.
   PubMed Web of Science ®Google Scholar
• Eggermont E. 2006. Recent advances in vitamin E metabolism and deficiency. European Journal of Pediatrics 165:429–434.
   PubMedGoogle Scholar
• Gerber A, Struy H, Weiss G, Lippert H, Ansorge S, Schulz HU. 2000. Effect of granulocyte colony-stimulating factor treatment on ex vivo neutrophil functions in nonneutropenic surgical intensive care patients. Journal of Interferon and Cytokine Research 20:1083–1090.
   PubMed Web of Science ®Google Scholar
• Hanson WR, Houseman KA, Collins PW. 1988. Radiation protection in vivo by prostaglandins and related compounds of the arachidonic acid cascade. Pharmacology and Therapeutics 39:347–356.
   PubMed Web of Science ®Google Scholar
• Herbert KE, Walkley CR, Winkler IG, Hendy J, Olsen GH, Yuan YD, Chandraratna RA, Prince HM, Levesque JP, Purton LE. 2007. Granulocyte colony-stimulating factor and an RARalpha specific agonist, VTP195183, synergize to enhance the mobilization of hematopoietic progenitor cells. Transplantation 83:375–384.
   PubMed Web of Science ®Google Scholar
• Hermans MH, van de Geijn GJ, Antonissen C, Gits J, van Leeuwen D, Ward AC, Touw IP. 2003. Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells. Blood 101:2584–2590.
   PubMed Web of Science ®Google Scholar
• Herodin F, Drouet M. 2005. Cytokine-based treatment of accidentally irradiated victims and new approaches. Experimental Hematology 33:1071–1080.
   PubMed Web of Science ®Google Scholar
• Herodin F, Grenier N, Drouet M. 2007. Revisiting therapeutic strategies in radiation casualties. Experimental Hematology 35:28–33.
   PubMed Web of Science ®Google Scholar
• Hofer M, Pospisil M, Znojil V, Hola J, Vacek A, Streitova D. 2008. Meloxicam, an inhibitor of cyclooxygenase-2, increases the level of serum G-CSF and might be usable as an auxiliary means in G-CSF therapy. Physiological Research 57:307–310.
   PubMed Web of Science ®Google Scholar
• Hofer M, Pospisil M, Znojil V, Hola J, Vacek A, Weiterova L, Streitova D, Kozubik A. 2006. Meloxicam, a cyclooxygenase 2 inhibitor, supports hematopoietic recovery in gamma-irradiated mice. Radiation Research 166:556–560.
   PubMed Web of Science ®Google Scholar
• Hosseinimehr SJ. 2007. Trends in the development of radioprotective agents. Drug Discovery Today 12:794–805.
   PubMed Web of Science ®Google Scholar
• Kalechman Y, Albeck M, Oron M, Sobelman D, Gurwith M, Seghal SN, Sredni B. 1990. Radioprotective effects of the immunomodulator AS101. Journal of Immunology 145:1512–1517.
   PubMed Web of Science ®Google Scholar
• Kalechman Y, Zuloff A, Albeck M, Strassmann G, Sredni B. 1995. Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0′)tellurate. Blood 85:1555–1561.
   PubMedGoogle Scholar
• Kumar KS, Srinivasan V, Toles R, Jobe L, Seed TM. 2002. Nutritional approaches to radioprotection: Vitamin E. Military Medicine 167:57–59.
   PubMedGoogle Scholar
• Kumar KS, Vaishnav YN, Weiss JF. 1988. Radioprotection by antioxidant enzymes and enzyme mimetics. Pharmacology and Therapeutics 39:301–309.
   PubMed Web of Science ®Google Scholar
• Larochelle A, Krouse A, Metzger M, Orlic D, Donahue RE, Fricker S, Bridger G, Dunbar CE, Hematti P. 2006. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood 107:3772–3778.
   PubMed Web of Science ®Google Scholar
• Mehrotra S, Mishra KP, Maurya R, Srimal RC, Singh VK. 2002. Immunomodulation by ethanolic extract of Boerhaavia diffusa roots. International Immunopharmacology 2:987–996.
   PubMed Web of Science ®Google Scholar
• Neta R, Oppenheim JJ, Douches SD. 1988. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. Journal of Immunology 140:108–111.
   PubMed Web of Science ®Google Scholar
• Neta R, Oppenheim JJ, Schreiber RD, Chizzonite R, Ledney GD, MacVittie TJ. 1991. Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance. Journal of Experimental Medicine 173:1177–1182.
   PubMed Web of Science ®Google Scholar
• Neta R, Perlstein R, Vogel SN, Ledney GD, Abrams J. 1992. Role of interleukin 6 (IL-6) in protection from lethal irradiation and in endocrine responses to IL-1 and tumor necrosis factor. Journal of Experimental Medicine 175:689–694.
   PubMed Web of Science ®Google Scholar
• Nicola NA, Metcalf D, Johnson GR, Burgess AW. 1979. Separation of functionally distinct human granulocyte-macrophage colony-stimulating factors. Blood 54:614–627.
   PubMed Web of Science ®Google Scholar
• Pulliam AC, Hobson MJ, Ciccone SL, Li Y, Chen S, Srour EF, Yang FC, Broxmeyer HE, Clapp DW. 2008. AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice. Experimental Hematology 36:1084–1090.
   PubMed Web of Science ®Google Scholar
• Rahu M. 2003. Health effects of the Chernobyl accident: Fears, rumours and the truth. European Journal of Cancer 39:295–299.
   PubMed Web of Science ®Google Scholar
• Singh VK, Shafran RL, Inal CE, Jackson WE III, Whitnall MH. 2005. Effects of whole-body gamma irradiation and 5-androstenediol administration on serum G-CSF. Immunopharmacology and Immunotoxicology 27:521–534.
   PubMed Web of Science ®Google Scholar
• Singh VK, Shafran RL, Jackson WE III, Seed TM, Kumar KS. 2006. Induction of cytokines by radioprotective tocopherol analogs. Experimental and Molecular Pathology 81:55–61.
   PubMed Web of Science ®Google Scholar
• Srinivasan V, Weiss JF. 1992. Radioprotection by vitamin E: Injectable vitamin E administered alone or with WR-3689 enhances survival of irradiated mice. International Journal of Radiation Oncology, Biology, Physics 23:841–845.
   PubMed Web of Science ®Google Scholar
• Uckun FM, Souza L, Waddick KG, Wick M, Song CW. 1990. In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice. Blood 75:638–645.
   PubMed Web of Science ®Google Scholar
• Vos O. 1992. Role of endogenous thiols in protection. Advances in Space Research 12:201–207.
   PubMedGoogle Scholar
• Waddick KG, Song CW, Souza L, Uckun FM. 1991. Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination. Blood 77:2364–2371.
   PubMed Web of Science ®Google Scholar
• Weaver CH, Schulman KA, Buckner CD. 2001. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: A randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim. Bone Marrow Transplantation 27(Suppl. 2):S23–29.
   Google Scholar
• Weiss JF, Srinivasan V, Kumar KS, Landauer MR. 1992. Radioprotection by metals: Selenium. Advances in Space Research 12:223–231.
   PubMedGoogle Scholar
• Wenisch C, Werkgartner T, Sailer H, Patruta S, Krause R, Daxboeck F, Parschalk B. 2000. Effect of preoperative prophylaxis with filgrastim in cancer neck dissection. European Journal of Clinical Investigation 30:460–466.
   PubMed Web of Science ®Google Scholar
• Whitnall MH, Elliott TB, Landauer MR, Wilhelmsen CL, McKinney L, Kumar KS, Srinivasan V, Ledney GD, Seed TM. 2002. Protection against gamma-irradiation with 5-androstenediol. Military Medicine 167:64–65.
   PubMedGoogle Scholar
• Whitnall MH, Inal CE, Jackson WE III, Miner VL, Villa V, Seed TM. 2001. In vivo radioprotection by 5-androstenediol: Stimulation of the innate immune system. Radiation Research 156:283–293.
   PubMed Web of Science ®Google Scholar